AI Agents for Regulatory

Revolutionizing Regulatory Document Creation

The Narrativa Navigator Platform simplifies regulatory writing with agentic AI-powered automation for CSRs, patient narratives, TLFs, eCTD documentation, redactions, and collaborative authoring. It helps life sciences teams streamline processes, reduce timelines, and deliver submission-ready content with confidence.

Talk to our teamTalk to our team

Life Sciences AI Agents

Discover how Narrativa uses AI Agents to transform Life Sciences

Agentic AI Automation for Regulatory Writing

Clinical regulatory writing is essential in the pharmaceutical industry, and the Narrativa Navigator platform empowers regulatory writers to automate processes, focus on strategic tasks, and produce high-quality, compliant documents with greater efficiency. By leveraging our Agentic AI-driven solution, pharmaceutical companies can streamline regulatory document generation—including the documents that populate eCTD submissions—enhance accuracy, and gain a competitive edge in an increasingly data-driven market.

Narrativa Solutions for Regulatory Writing

Narrativa Solutions

Clinical Atlas

Clinical Atlas is your medical writer’s companion for generating regulatory documentation.

Clinical Atlas

CSR

Clinical Atlas automates the creation of Clinical Study Reports by extracting data directly from TLFs and converting them into clear, submission-ready narratives. AI Agents handle data interpretation, table to text generation, semantic search for information extraction and quality validation — with full traceability from every data point back to its source.

Clinical Atlas

Protocol

Clinical Atlas deploys specialized Protocol AI Agents to automate the entire protocol authoring process — from study synopsis to submission-ready document. AI Agents for protocol design, burden analysis, study population evaluation, and compliance auditing work together to produce structured, compliant protocols in hours instead of weeks.

Other Key Solutions

Narrativa Solutions

Narrative Pathway

Simplify the creation of patient narratives by automatically transforming clinical data into clear, consistent summaries.

Narrativa Solutions

TLF Voyager

With TLF Voyager, the generation of tables, listings, and figures, are automated to boost clinical reporting efficiency.

Narrativa Solutions

Redaction Scout

With Redaction Scout , you can automate the anonymization and redaction of documents are datasets.

Streamlining regulatory writing with AI-driven precision

Life sciences teams face increasing pressure to produce large volumes of accurate and consistent regulatory documents while meeting complex compliance requirements. Medical writers must transform data from clinical trials into structured reports—a process that is traditionally manual, time-consuming, and prone to errors. This challenge intensifies when preparing eCTD submissions, where content must be consistent across multiple sections, aligned with evolving requirements from authorities such as the FDA and EMA, and managed through iterative revisions involving multiple stakeholders.

Narrativa Navigator leverages advanced Agentic AI to automate drafting, formatting, and content adaptation, streamlining the creation of regulatory documents and review workflows. The platform supports the reuse of previously approved content by integrating and reformatting it for new submissions while ensuring consistency and regulatory compliance. Its Agentic AI capabilities also enable intelligent content generation, cross-referencing, and version control—improving traceability and simplifying the review process across all regulatory documentation, including eCTD filings. By combining automation with proactive data quality control, the platform reduces review cycles, ensures audit-ready outputs, and frees medical writers to focus on high-value tasks—delivering accurate, compliant documents faster and accelerating time-to-market for new therapies.

Key Benefits of Agentic AI Regulatory Automation

Improved Compliance & Traceability

Regulatory submissions demand transparent audit trails and adherence to global guidelines. AI-powered solutions support traceability by tracking source data, version history, and content changes—including cross-references across eCTD document versions—helping regulatory teams maintain compliance with agencies like the FDA and EMA.

Accelerated Submissions

AI Agents can automatically generate first drafts of clinical and regulatory content, dramatically reducing time spent drafting documents. This acceleration helps teams meet deadlines and deliver submission‑ready content with greater speed.

Cost Reduction
Avoid millions in lost revenue caused by delays—where even a single day can cost hundreds of thousands—by automating document generation and streamlining submission workflows.
End-to-End Automation

Leverage AI Agents to autonomously generate, update, and manage regulatory documents (eCTD modules, CSRs, narratives, TLFs), reducing reliance on manual, resource-intensive processes. The platform also supports the reuse and adaptation of previously approved content for new submissions, ensuring consistency and compliance across filings.

Scalability Across Studies

With AI support, medical writing teams can handle multiple projects in parallel without sacrificing quality. This scalability is especially valuable for sponsors, Contract Research Organizations (CROs), and biotech firms managing concurrent clinical programs.

Consistency & Standardization

Maintain uniform language, structure, and formatting across all regulatory documents—including eCTD sections—reducing variability and improving submission quality. AI Agents standardize tables, styles, and structures to ensure alignment with regulatory expectations across authorities.

Improved Accuracy
By standardizing terminology, formatting, and style across multiple deliverables, AI reduces human error and ensures uniformity across documents. This consistency is critical for regulatory reporting, where precision and clarity are non‑negotiable.
Focus on High‑Value Tasks

By automating repetitive writing and formatting work, AI frees writers to concentrate on strategic decision‑making, scientific interpretation, and critical review. This shift enhances team productivity and elevates the overall quality of outputs.

Agentic AI in Regulatory Processes

Agentic AI in regulatory automation refers to advanced artificial intelligence systems capable of understanding structured and unstructured clinical data and autonomously generating high-quality regulatory documents. Unlike traditional automation tools, agentic AI can interpret inputs, apply context, and produce human-like narratives tailored to regulatory standards. This technology enables pharmaceutical and biotech companies to transform large volumes of clinical data into submission-ready content in a fraction of the time required by manual processes.

Agentic AI significantly enhances medical writing by automating the generation of complex regulatory documents. It can process millions of data points within seconds and generate complete drafts that require minimal human intervention. This allows medical writers to shift their focus from repetitive writing tasks to strategic and scientific contributions, improving both productivity and job satisfaction while maintaining high-quality outputs.

Agentic AI simplifies the Medical Writing process by:

  • Processing large volumes of structured and unstructured data in seconds
  • Generating high-quality drafts that require minimal human intervention
  • Standardizing content, structure, and formatting across multiple outputs
  • Reusing previously approved content to save time and maintain consistency

Automating regulatory documents is no easy feat. It involves analyzing and connecting millions of data points to produce documents like patient safety narratives. Agentic AI must not only understand the information in these datasets but also reason logically. Why? The generated content that populates CSRs and other regulatory documents must be coherent, accurate, and easily understandable to reviewers. By leveraging advanced AI reasoning, Navigator sequences information into a cogent flow that mirrors how a skilled medical writer would organize the content.

Preparing documents for regulatory submissions involves:

  • Consolidating and integrating data collected before, during, and after clinical trials from multiple sources, including case report forms (CRFs), tables, listings, and figures (TLFs).
  • Reviewing, interpreting, and structuring information from thousands of patients across global study sites.
  • Drafting Clinical Study Reports (CSRs) and patient narratives.
  • Compiling and validating Tables, Listings, and Figures (TLFs).
  • Formatting content consistently across multiple reports and sections.
  • Ensuring compliance with the strict requirements of regulatory authorities, such as the FDA and EMA.
  • Managing a traditionally manual, resource-intensive, and time-consuming workflow requiring significant effort from medical writers.

Integrating AI into regulatory workflows enables seamless collaboration between data, technology, and medical writing teams. AI platforms can connect with existing clinical data systems, automate document generation, and support end-to-end regulatory processes. This integration enhances efficiency, reduces bottlenecks, and ensures that documentation is always audit-ready and compliant.

As clinical data volumes continue to grow, agentic AI is becoming essential for scalable regulatory operations. Pharmaceutical and biotech companies adopting AI-driven automation are better positioned to reduce delays, control costs, and accelerate time-to-market.

Intelligent systems will increasingly support proactive compliance by monitoring regulatory changes and helping organizations keep documentation—including eCTD filings—aligned with current requirements. At the same time, adaptive learning capabilities will allow Agentic AI to improve continuously based on prior submissions and user interactions, enabling more informed decision-making, better anticipation of regulatory expectations, and more efficient submission strategies.

By leveraging advanced AI technologies, organizations can modernize their regulatory strategies and stay competitive in an increasingly data-driven industry.

The electronic Common Technical Document (eCTD) is a standardized format used by pharmaceutical companies to submit regulatory information to health authorities such as the FDA and EMA. It is structured into five main sections covering administrative information, summaries, quality, nonclinical study reports, and clinical study reports. Together, these components provide the data required to demonstrate the safety, efficacy, and quality of a medicinal product.

Preparing eCTD documentation is a complex and time-intensive process involving multiple stakeholders and iterative revisions. Ensuring consistency across documents, maintaining alignment with evolving regulatory requirements, and managing content reuse across submissions can introduce significant operational challenges.

Narrativa addresses these challenges by automating the creation, transformation, and management of the documents that form part of the eCTD. Rather than automating entire eCTD sections, the platform focuses on streamlining the generation, formatting, and maintenance of the individual documents within those sections. Specifically, Narrativa can:

Automatically generate and transform documents that populate eCTD sections, reducing manual authoring effort

Reuse and adapt approved content for new submissions while maintaining compliance

Identify and update content that no longer aligns with current regulatory requirements

Manage cross-references and track changes across document versions for full traceability

Standardize formatting, structure, and tables across all documentation

Support regulatory, medical writing, and associated teams throughout the documentation lifecycle

As regulatory demands continue to evolve, intelligent AI systems will increasingly support proactive compliance by monitoring regulatory changes and helping organizations keep documentation aligned with current requirements. Adaptive learning capabilities will allow Agentic AI to improve continuously based on prior submissions and user interactions, enabling more informed decision-making and more efficient submission strategies.